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Abstract
Classical bovine spongiform encephalopathy (BSE) is an acquired prion disease that is invariably fatal in cattle and has been
implicated as a significant human health risk. Sequence variations in the coding region of the prion gene (PRNP) have been
associated with acquired transmissible spongiform encephalopathy (TSE) susceptibility in mammals; however, this is not the
case in cattle. It has been hypothesized that genes, in addition to the prion gene, contribute to genetic susceptibility of
acquired TSEs. Accordingly, genetic studies of classical BSE in cattle identified loci other than PRNP that are associated with
disease incidence. The objective of this study was to utilize a genome-wide association study to test for genetic loci
associated with classical BSE. The samples include 143 BSE affected (case) and 173 unaffected half sib (control) animals
collected in the mid 1990s in Southern England. The data analysis identifies loci on two different chromosomes associated
with BSE disease occurrence. Most notable is a single nucleotide polymorphism on chromosome 1 at 29.15 Mb that is
associated with BSE disease (p=3.09E-05). Additionally, a locus on chromosome 14, within a cluster of SNPs showed a trend
toward significance (p=5.24E-05). It is worth noting that in a human vCJD study markers on human chromosome 8, a
region with shared synteny to the region identified on cattle chromosome 14, were associated with disease. Further, our
candidate genes appear to have plausible biological relevance with the known etiology of TSE disease. One of the candidate
genes is hypothetical gene LOC521010, similar to FK506 binding protein 2 located on chromosome 1 at 29.32 Mb. This gene
encodes a protein that is a member of the immunophilin protein family and is involved in basic cellular processes including
protein folding. The chromosomal regions identified in this study and candidate genes within these regions merit further
investigation.
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Introduction
Transmissible spongiform encephalopathies (TSEs), also known
as prion diseases, are a group of invariably fatal mammalian
neurodegenerative diseases [1]. TSEs are unique in that they can
manifest through inherited, sporadic or acquired origins [2].
Classical bovine spongiform encephalopathy (cBSE) is an acquired
TSE that is transmissible through the consumption of meat and/or
bone meal contaminated with the infectious prion agent. Dietary
exposure to food contaminated with the BSE agent is the
suspected primary cause of the human TSE, variant Creutzfeldt-
Jakob Disease (vCJD) [3–6].
The prion protein is a glycosyl-phosphatidylinositol (GPI)
anchored protein that has a native form (PrP
c) for which the
secondary structure consists predominantly of alpha-helices. The
disease-associated form, PrP
Res, has a substantial increase in the
beta-pleated sheet content and reduction of the alpha-helices in
comparison to the native form [7]. The presence of PrP
Res
promotes the conversion of native PrP
c to PrP
Res via a mechanism
that is to date not completely understood [8]. This altered protein
conformation is associated with an increased resistance to
digestion by proteinase K [9]. As a consequence of this resistance
to protein degradation, the accumulation of PrP
Res within neurons
results in the characteristic plaques that are part of the etiology of
prion disease.
Moreover, the accumulation of abnormally folded prion protein
within the central nervous system mediates a conformational
change in the native host protein to a protease-resistant form of the
prion protein [1,2]. The central nervous system (CNS) is the
primary tissue where the disease form of the protein accumulates.
However, in the case of acquired TSEs the infectious agent is
thought to be transmitted through the Peyer’s patches in the
intestine, to the CNS [10].
Expression of the prion protein is essential for the development
of TSEs [11], and sequence variations in the prion gene (PRNP)
have been associated with TSE susceptibility in humans, mice,
sheep, deer and to a lesser extent cattle [10]. Specific
polymorphisms in the coding region of PRNP in humans and
sheep are associated with acquired TSE susceptibility [12–14]. In
general this is not the case in cattle, although alleles and
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bovine PRNP promoter region have been associated with incidence
of classical bovine spongiform encephalopathy (BSE) [15–19]. It
has been hypothesized that genes, in addition to the prion gene,
contribute to genetic susceptibility of acquired TSEs. Genome-
wide studies in sheep [20–22], mice [23–25], and humans [26]
have identified chromosomal regions, other than the prion gene,
that contribute to TSE disease progression. Furthermore, genetic
studies of classical BSE in cattle identified loci other than PRNP
(located on chromosome 13 at 47.2 Mb) that are associated with
disease incidence [27–29].
The studies that have been performed with cattle thus far use
relatively low density panels of either microsatellite or SNP
markers. With recent advancements in sequencing and SNP
marker technology it is possible to perform an association analysis
with greater resolution to those previously described. As a result
the current genome-wide association study allows insight into two
important questions. The first is whether an analysis with a higher
resolution scan identify novel genomic regions associated with
classical BSE. Secondly, whether such an analysis can confirm
and/or refine the previously identified genomic regions and
ultimately identify positional candidate genes.
The objective of this study was to utilize a high-density whole
genome association study to identify genetic loci associated with
classical BSE. The animals used are female Holstein cattle from
the UK, that contracted BSE in the mid- 1990’s, along with
matched half-sib controls. The BSE cases were identified on
commercial farms where the most likely source of disease was
through consumption of contaminated feed prior to and during
the BSE epidemic in the United Kingdom. The BSE cases were
paired with age matched half-sib controls from the same calving




This study used DNA extracted from blood samples of Holstein
cows that were diagnosed as BSE positive and half-sib controls
collected in the mid 1990s in Southern England. The samples
included 143 BSE affected (case) and 173 unaffected (control)
animals. In addition 15 BSE negative animals, defined by post-
mortem histology, were included in the control set. BSE positive
cattle were examined by qualified veterinarians and their BSE
status was subsequently confirmed post-mortem by histology (by
the Veterinary Laboratories Agency, New Haw, Surrey, UK).
Control animals were contemporary age matched half siblings (the
same sire and different dams) of BSE cases, from the same calving
season and farm and were healthy at the time samples were
collected. As such, the control animals are assumed to have been
exposed to the same environment. The dendrogram showing
relationships among the samples is shown in Figure 1.
Genotyping and Data quality control
The 316 BSE case and control samples were genotyped with a
Illumina bovine SNP50 beadchip with more than 58k SNPs
following the manufacturers recommended protocol (Illumina
Inc., San Diego, CA). Genotypes were called using the BeadStudio
software (Illumina Inc.) and processed through the automated
genotype calling. Genotypes were then subjected to data quality
control parameters.
For the case-control sample set from the original 58,336 SNPs
in the assay, 1389 SNPs were excluded based on assay failure, as
observed by poor clustering of alleles using the BeadStudio
software. The remaining 56,947 SNPs were analyzed for quality
control through the summary statistics of the PLINK program
[30] and 2,065 SNPs were removed because more than 10% of the
samples failed to genotype at that locus (GENO.0.1). Addition-
ally, 5 samples were removed due to low genotyping rate
(MIND.0.1). A further 8,739 SNPs were removed due to a
minor allele frequency (MAF),0.01. The remaining individuals
that were included in the analyses had a mean genotyping rate of
0.97. Of these, an average 48,053 passed quality control measures
and had an average genotyping success rate of 0.97.
Multi-dimensional scaling (MDS) of the matrix of genome-wide
identity-by-state (IBS) distances was used to provide a two-
dimensional projection of the data onto axes representing
components of genetic variation. Animals whose genetic ancestry
differs significantly appear as outliers on the MDS plot. The
genome-wide IBS pair-wise identities between each pair of animals
were calculated using PLINK [30]. These IBS-relationships were
converted into genetic distances by subtracting them from one,
and the matrix of pair-wise IBS distances was used as input for
multi-dimensional scaling. Thus population stratification was
tested for in this data set and none was observed (Figure 2).
Statistical analysis
The PLINK software v1.04 was used to perform the statistical
analysis [30]. The genotypic data from the BSE case and control
sample set were analyzed using the case-control association (x
2)
test. Additionally using the max (T) permutation within PLINK
software, the data was subjected to 1,000,000 permutations and
the p-values reported. Further to the allelic association test,
associations were analyzed with the dominant and the recessive
Figure 1. Dendrogram showing the relationship of BSE positive (case) and control samples. Derived from genotypic data use R 2.9.0.
cluster diagram statisical software.
doi:10.1371/journal.pone.0026819.g001
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(d.f.). Uncorrected p-values of 5E-5 were considered moderate
evidence of statistical significance and this is further supported by
the permuted p-values. All of the plots and figures were produced
using R statistical analyses. Physical positions and alleles are
expressed in terms of the forward strand of the reference genome
(BTAU4.0, ftp://ftp.hgsc. bcm.tmc.edu/pub/data/Btaurus/).
Results
Case-control association analysis for BSE Incidence
The case-control samples were comprised of 143 BSE case and
173 control animals. The control samples included at least one
animal from the same farm as each of the BSE cases and an
additional 15 BSE negative animals. All samples were genotyped
with the bovine SNP50 beadchip that consisted of greater than
58K SNPs dispersed across the genome with an average interval of
37 kb [31]. Of these markers, an average 48,053 SNPs passed
quality control measures outlined in the material and method
section with an average genotyping success rate of 0.97. These
data were analyzed for association with disease status using the
case-control allelic test within the PLINK software [30].
An allelic association analysis of the 316 animal across 48,053
SNPs revealed 1 SNP on chromosome 1 at 29,147,078 bp with a
significant (p=3.09E-5) over representation in BSE affected
animals. Possibly of greater interest was a locus on chromosome
14 where, although the peak SNP at 43,984,235 bp did not
research significance (p=5.24E-05) it was within a cluster of SNPs
above background (see Table 1 and Figure 3). Additionally
markers on chromosomes 5, 10, 14, 15, 17, 21 and 24 had P values
approaching significance (p#5E-4).
The data set was analyzed with a best fit model test in which
standard allelic, trend, dominant, recessive and genotypic
association tests were performed. The test result with the lowest
p value is reported in Table 2. In addition to the loci already
identified on chromosome 1 and 14, the best fit model identified
three SNPs with recessive and two SNPs with dominance effects.
Specifically, SNP on chromosomes 2, 3 and 21 exhibited
suggestive associations with BSE under a recessive model while
loci on chromosomes 14 and 24 exhibited suggestive associations
under a dominance model. The locus at 45,169,821 bp on
chromosome 14 (associated with the dominance model) is in close
proximity (,1.2 Mb away) to the loci identified in the allelic
association (see Table 2).
Figure 2. Multi-dimensional Scaling (MDS) of the BSE case and half-sib control set sample set.
doi:10.1371/journal.pone.0026819.g002
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Classical BSE
Classical BSE disease is a difficult phenotype to define. Animals
that have developed BSE are clearly susceptible. However, those
appearing clinically healthy may either be incubating disease
though clinically asymptomatic, may be in fact resistant to disease,
or may not have been sufficiently exposed to the infectious agent.
Alternatively, they may have been less susceptible to the disease
through resistance or requirement for higher infectious dose for
acquisition of disease. Because disease is thought to occur
following migration of the infectious agent from the intestine to
the brain, multiple genes are likely to be involved in the acquisition
and transfer of the agent as well as progression to disease.
Consequently, the development of classical BSE may involve the
interaction and possibly subtle effects of several contributing loci
and is likely to be a complex trait involving genes expressed
differentially in several tissues. Therefore, it is important to
consider this when examining and interpreting the results for
evidence of associations between disease and genetic loci.
Specifically, the balance of applying stringent multiple testing
corrections, such as Bonferroni, to a phenotype such as this may be
overly prone to type II errors and discarding real, though subtle
associations versus a type I errors that generates false positives.
Additionally, because this case control analysis used samples from
naturally infected cattle during the UK epidemic the number of
contemporaneous controls was limited and thus limits the power of
this study. The power of this study has a range from 0.58 to 0.85
depending on the unknown probability of exposure in the control
animals. A larger number of samples would have increased the
power to detect significant loci, however this study utilized the
largest number of samples available to us.
Associations with classical BSE disease presence or
absence
The higher resolution genomic analyses utilized in this study
have identified loci on several different chromosomes that are
Figure 3. Genome-wide plot of 2log10 p-values of loci from BSE case-control allelic association analysis. Bovine autosomes 1–29 and
Chromosome X are shown by different colors. The horizontal lines show moderate (5E-5) and high (5E-7) significance thresholds.
doi:10.1371/journal.pone.0026819.g003
Table 1. Allelic association analysis of 50 K SNPs with BSE occurrence.





1 29.1 BTB-01333940 A G 0.15 0.05 3.09E-05* 3.225 3.70E-05
5 8.4 BFGL-NGS-117339 G A 0.28 0.42 3.66E-04 0.528 4.23E-03
10 29.2 BTB-01261410 A C 0.52 0.38 2.55E-04 1.808 1.72E-04
14 44.0 Hapmap57707-rs29024913 A G 0.48 0.32 5.24E-05 1.945 5.40E-05
14 45.2 ARS-BFGL-BAC-23887 G A 0.55 0.40 2.23E-04 1.812 1.20E-04
15 35.7 ARS-BFGL-NGS-65959 A G 0.38 0.24 1.91E-04 1.914 1.08E-04
17 41.0 Hapmap43651-BTA-67415 A G 0.31 0.45 3.34E-04 0.550 5.20E-04
21 13.2 Hapmap42965-BTA-53492 G A 0.53 0.38 2.40E-04 1.810 1.44E-04
24 1.5 ARS-BFGL-NGS-11247 C A 0.20 0.34 1.36E-04 0.494 2.55E-04
A1 is the major allele and A2 is the minor allele. The frequency of the major allele in the BSE affected (F-A), and unaffected (F-U) animals. Allelic association unadjusted
p-value and OR is the Odds Ratio and p-value after 1,000,000 permutation.
*denotes moderate significance.
doi:10.1371/journal.pone.0026819.t001
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nucleotide polymorphism on chromosome 1 at 29.15 Mb that is
significantly (p=3.09E-05) associated with BSE disease, suggesting
that this is functionally pertinent to risk of disease acquisition and/
or progression. Similarly, another locus, on chromosome 14 at
32.4 Mb, (p=5.24E-05), is identified to be associated with BSE
disease. The results on chromosome 14 are further supported by a
SNP 1.2 Mb away that is also associated both in a dominance
model (6.44E-05) and in an allelic model (2.23E-04) with disease.
Additionally, there is evidence of associations with absence of
disease in control animals on two chromosomes. A locus on
chromosome 3 at 32.4 Mb was associated (p=5.87E-05) with the
absence of disease under a recessive model, whereas a locus on
chromosome 24 showed an association (p=6.45E-05) under a
dominance model.
Regions identified in previous analysis and studies in
Holstein cattle
Samples used in this study overlap with a subset of those in our
previous study [29], and therefore the results are not completely
independent. However, the most convincing evidence that
previously reported associations are valid is the fact that they
were again identified in this higher resolution genomic analysis
and with a different sample set to previous studies [27,28]. The
locus on chromosome 1 was the most significant in the present
study. An association on this chromosome was also identified by
Zhang et al. [28] in a low density QTL study, and although the
position of the peak LOD score in that study was at the other end
of the chromosome the SNP identified here was within the 95%
confidence interval. The region identified in this study on
chromosome 14 was also previously reported [29], using the same
samples but with a different set of SNPs and as such this represents
a technical verification of the earlier data. It is worth noting,
however, that in a study of genetic control of CJD in humans,
markers on human chromosome 8 that share conservation of
synteny with the region of cattle chromosome 14 were identified
[26]. With the exception of the locus on chromosome 3, which has
not been previously reported as associated with BSE, all other
associations identified in this study provide confirmation of
associations identified in previous studies using a lower density
and different markers [27–29] (see Table 3). This study, like others
[22–25], indicates the presence of multiple loci on a number of
chromosomes that may have subtle effects on BSE susceptibility.
Candidate genes
In a 2006 review, Mabbott and MacPherson discussed how the
identification of the route of oral transmission, from the site of
infection to the brain, may facilitate the development of treatments
for TSEs. This process would include, transport of the prion across
the gut epithelium, transport to follicular dendritic cells,
accumulation in lympheatic cells and tissues and progression from
lymphatic tissues to tissues of the CNS including the brain [10]. To
this end our study employed a genomic approach to elucidate
chromosomal regions of association with disease or absence of
disease. It is useful to characterize whether genes in the identified
regions may reflect a physiological contribution to the transmission
pathway of infectious prions from the gut to the brain. Some of our
candidate genes appear to have attributed biological functions that
may intuitively be associated with the known etiology of TSE
disease, specifically the candidate gene, hypothetical gene
LOC521010, similar to FK506 binding protein 2 located on
chromosome 1 at 29,316,874 bp. This gene encodes a protein that
is a member of the immunophilin protein family and is involved in
basic cellular processes including protein folding. The encoded
protein of this gene is a cis-trans prolyl isomerase, similar to
cylclophilin A, and binds the immunosuppressants, FK506 and




(Mb) SNP ID A1 A2 TEST p-value
1 29.1 BTB-01333940 A G ALLELIC 3.09E-05*
2 108.6 BTA-48618-no-rs G A REC 9.10E-05
3 32.4 ARS-BFGL-NGS-
104661
A C REC 5.87E-05
14 44.0 Hapmap57707-
rs29024913
A G ALLELIC 5.24E-05
14 45.2 ARS-BFGL-BAC-
23887
G A DOM 6.44E-05
21 13.2 Hapmap42965-
BTA-53492
G A REC 9.30E-05
24 1.5 ARS-BFGL-NGS-
11247
C A DOM 6.45E-05
Duplicate loci were removed and unadjusted p-values are reported.
*denotes moderate significance.
doi:10.1371/journal.pone.0026819.t002
Table 3. Comparison of loci identified in this study with those previously reported.
CHR Position Mb SNP p-value Previously observed Study Location Mb
1 29.1 BTB-01333940 3.09E-05 Yes [28,29] 89.7
2 108.6 BTA-48618-no-rs 9.10E-05 Yes [29] 37.1
3 32.4 ARS-BFGL-NGS-104661 5.87E-05 no
5 8.4 BFGL-NGS-117339 3.66E-04 Yes [27,29] 30.6
10 29.2 BTB-01261410 2.55E-04 Yes [27,29] 21.1
14 44.0 Hapmap57707-rs29024913 5.24E-05 Yes [26,29] 44.0
15 35.7 ARS-BFGL-NGS-65959 1.91E-04 Yes [29] 35.7
17 41.0 Hapmap43651-BTA-67415 3.34E-04 Yes [28,29] 44.2
21 13.2 Hapmap42965-BTA-53492 9.30E-05 Yes [29] 33.2
24 1.5 ARS-BFGL-NGS-11247 6.45E-05 Yes [29] 18.5
doi:10.1371/journal.pone.0026819.t003
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genomic region with disease is far from a confirmation of a
causative role, it is within logic to speculate how this gene may be
related to the known parameters of TSE disease. It is well accepted
that the pathology associated with TSEs includes the alteration of
protein folding of the native PrP
c to a misfolded conformation
PrP
Res and therefore the identification of this gene known to
transcribe a protein involved in intracellular protein folding is at a
minimum, compelling.
The SNP located on BTA 14 (43.9 Mb), associated with BSE
disease case-control analysis, is in close proximity to the gene
exostoses (multiple) 1, EXT1. McCormick et al. [32], showed that
EXT1 is an endoplasmic reticulum (ER)-resident type II
transmembrane glycoprotein whose expression in cells results in
the alteration of the synthesis and display of cell surface heparin
sulfate glycosaminoglycans (GAGs). The N terminus of PrP
contains a GAG-binding motif and it is thought that PrP binding
of GAG is important in prion disease [33]. Again, if one considers
that the PrP contains a binding motif for cell surface GAGs, then a
gene such as exostoses may provide a means for PrP to adhere to
gastrointestinal and neural cells, and thus this candidate gene may
be important in the disease acquisition and progression.
Additional positional candidate genes of interest on chromo-
some 3 approaching significance include: leucine-rich repeats and
immunoglobulin-like domains 2, LRIG2, a protein which
participates in protein-protein interactions as well as Repulsive
guidance molecule family member A, a glycosyl phosphatidylino-
sitol-anchored glycoprotein that functions as an axon guidance
protein in the central nervous system. The functions of the
candidate genes identified in this study infer a role in the disease
etiology especially those related to immunological tissue and
neuronal tissue transport mechanisms.
Ideally it would be of interest to test if the associations identified
in this study would replicate in an additional sample set. However,
as these samples were collected during the UK BSE epidemic the
availability of contemporaneous controls are limited. Regardless
the validation of these associations in either another cattle
population or species would be extremely useful. Additionally, it
is important to emphasize that the candidate genes identified
through this genomic association study neither confirm nor imply
direct involvement of these genes in the disease process. Future
studies directed at assessing these genes are necessary to identify
any physiological relationships between their functions and the
incidence of TSE disease.
Conclusion
We [29] and others [9,22–28] hypothesize the involvement of
genes in addition to the prion gene in the progression of prion
diseases. In particular work by Mead S. et al. 2009, used a genome-
wide association study to identify genetic risk factors for vCJD
where the genetic region that they identified comparatively
overlaps that which we identified [26]. This high-density
genome-wide association analysis identified a SNP on bovine
chromosome 1 that was significantly associated with BSE disease.
Moreover, the locus on chromosome 14 confirms an association
identified in an earlier study [29] and at a region of conserved
synteny with human chromosome 8 where an association has been
reported with vCJD [26].
We report data that demonstrate an association of specific
regions in cattle with classical BSE disease occurrence. Informa-
tion regarding the involvement of genes, in addition to the prion
gene, in the progression of prion disease is invaluable and merit
further investigation. Not only will it enable us to gain a better
understanding of the pathobiology of prion diseases but may also
provide insight towards development of effective gene-specific
treatments of Prion related diseases.
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